Guidelines

New consensus on thyroid eye disease prompts some debate


 

Consensus statement not a guideline

The groups noted that the consensus statement is not meant to be a clinical practice guideline and was not written to “establish a standard of care, replace sound clinical judgment, or capture all nuances likely to be present in any particular patient,” and “specific outcomes are not guaranteed.”

What the statement is intended for is to “provide a concise and timely appraisal of a rapidly changing therapeutic arena” for practicing endocrinologists, they explained.

Overall, the authors recommend an individualized management approach, based on factors ranging from disease severity, duration, its impact on daily living, patient age, comorbidities, and importantly, the costs of therapies.

Ultimately, patient satisfaction is essential in TED management, Dr. Burch added.

“Consideration of the impact of TED on patient’s satisfaction with their appearance and visual functioning is a key component in management decisions concerning TED.”A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Keeping thyroid hormone treatment on target is key for the heart
MDedge Internal Medicine
Hypothyroidism: No more waiting to eat or drink with liquid thyroxine?
MDedge Internal Medicine
Hyperthyroidism rebound in pregnancy boosts adverse outcomes
MDedge Internal Medicine
Thyroid autoimmunity linked to cancer, but screening not advised
MDedge Internal Medicine
Don’t be afraid of weight gain with hyperthyroid treatment
MDedge Internal Medicine
Stopping levothyroxine in subclinical hypothyroidism safe, feasible
MDedge Internal Medicine
USPSTF holds firm on postmenopausal hormone recommendations
MDedge Internal Medicine
Thyroid nodule volume reduction correlates with energy in ablation
MDedge Internal Medicine
‘Game changer’: Thyroid cancer recurrence no higher with lobectomy
MDedge Internal Medicine
Lifestyle choices could curb genetic risk for thyroid cancer
MDedge Internal Medicine